Extracellular vesicles as natural therapeutic agents and innate drug delivery systems for cancer treatment : Recent advances, current obstacles, and challenges for clinical translation

Research output: Journal Publications and Reviews (RGC: 21, 22, 62)21_Publication in refereed journalpeer-review

11 Scopus Citations
View graph of relations

Author(s)

  • Marco Pirisinu
  • Tran Nguyen Hong
  • Lap Thi Nguyen

Detail(s)

Original languageEnglish
Journal / PublicationSeminars in Cancer Biology
Online published22 Sep 2020
Publication statusOnline published - 22 Sep 2020

Abstract

As cancer poses a significant threat to the well-being of humans on a global scale, many researchers have embarked on the search for effective anticancer therapeutic agents. In recent years, many drugs have been shown to have extraordinary anticancer effects. However, in a lot of cases the treatment is accompanied by undesirable side effects due to some intrinsic properties linked to the therapeutic agents, such as poor targeting selectivity and short half-life in the circulation. In this regard, extracellular vesicles (EVs), a diverse family of natural cell-derived vesicles, steal the show as potential anticancer immunotherapy or delivery vectors of anticancer agents since they are an innate mechanism of intercellular communication. Here, we describe some of the most hotly-debated issues regarding the use of EVs as anticancer therapeutics. First, we review the biology of EVs providing the most up-to-date definition of EVs as well as highlighting their circulation kinetics and homing properties. Next, we share our views on popular methods reported for EV isolation, characterization, and functional analysis. Pioneering and innovative reports along with emerging challenges in the field of EV imaging and EV drug loading strategies are then discussed. Finally, we examine in detail the therapeutic application of EVs in cancer treatment, including their role in cancer immunotherapy and as natural delivery systems for anticancer agents including natural compounds such as paclitaxel and doxorubicin. We consider standardised protocols and proper analytical approaches to be crucial in improving the reproducibility and rigor in EV research and ensuring the successful translation of EVs as anticancer therapeutics.

Research Area(s)

  • Drug delivery, Extracellular vesicles, Nanomedicine, Natural compounds

Citation Format(s)

Extracellular vesicles as natural therapeutic agents and innate drug delivery systems for cancer treatment : Recent advances, current obstacles, and challenges for clinical translation. / Pirisinu, Marco; Pham, Tin Chanh; Zhang, Daniel Xin; Hong, Tran Nguyen; Nguyen, Lap Thi; Le, Minh TN.

In: Seminars in Cancer Biology, 22.09.2020.

Research output: Journal Publications and Reviews (RGC: 21, 22, 62)21_Publication in refereed journalpeer-review